Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease
about
Current management of autosomal dominant polycystic kidney diseasePolycystic liver diseases: advanced insights into the molecular mechanismsBeneficial effect of combined treatment with octreotide and pasireotide in PCK rats, an orthologous model of human autosomal recessive polycystic kidney diseaseTherapeutic Targets in Polycystic Liver Disease.Effect of captopril and telmisartan on methotrexate-induced hepatotoxicity in rats: impact of oxidative stress, inflammation and apoptosis.
P2860
Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@ast
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@en
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@nl
type
label
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@ast
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@en
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@nl
prefLabel
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@ast
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@en
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@nl
P2093
P2860
P1433
P1476
Telmisartan ameliorates fibroc ...... sive polycystic kidney disease
@en
P2093
Daisuke Yoshihara
Koichi Nakanishi
Mai Sasaki
Masanori Kugita
Shigeo Horie
Shizuko Nagao
Takaaki Abe
Tamio Yamaguchi
P2860
P304
P356
10.1371/JOURNAL.PONE.0081480
P407
P577
2013-01-01T00:00:00Z